Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,153 | 1,460 | 6,615 | 4,628 | 3,369 |
| Depreciation Amortization | 1,298 | 647 | 2,435 | 1,792 | 1,172 |
| Accounts receivable | -563 | 286 | 1,400 | 491 | 786 |
| Accounts payable and accrued liabilities | -2,737 | -2,728 | 1,935 | -330 | -330 |
| Other Working Capital | -3,065 | -1,861 | 3,724 | -5,625 | -5,218 |
| Other Operating Activity | 3,300 | 2,443 | -3,160 | -143 | -439 |
| Operating Cash Flow | $1,385 | $246 | $12,950 | $811 | $-660 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -367 | N/A | -14,978 | -13,135 | -12,424 |
| Net Acquisitions | N/A | N/A | -207 | -207 | -206 |
| Purchase Sale Intangibles | N/A | N/A | -887 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -887 | 0 | 0 |
| Investing Cash Flow | $-367 | $N/A | $-16,072 | $-13,342 | $-12,630 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 10,301 | N/A | 0 |
| Debt Repayment | N/A | N/A | -4,704 | N/A | N/A |
| Other Financing Activity | 3,159 | -1,623 | -11,433 | 3,542 | 3,537 |
| Financing Cash Flow | $3,159 | $-1,623 | $-5,836 | $3,542 | $3,537 |
| Exchange Rate Effect | 304 | 160 | 633 | 201 | 40 |
| Beginning Cash Position | 26,827 | 26,827 | 35,152 | 35,152 | 35,152 |
| End Cash Position | 31,307 | 25,609 | 26,827 | 26,366 | 25,440 |
| Net Cash Flow | $4,480 | $-1,218 | $-8,325 | $-8,786 | $-9,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,385 | 246 | 12,950 | 811 | -660 |
| Capital Expenditure | -367 | N/A | -14,978 | -13,135 | -12,424 |
| Free Cash Flow | 1,017 | 246 | -2,029 | -12,324 | -13,084 |